Evidence of oral translocation of anionic G6.5 dendrimers in mice

Molecular Pharmaceutics

Volumn 10, Issue 3, 2013, Pages 988-998

  Thiagarajan, Giridhar ^a,b   Sadekar, Shraddha ^b   Greish, Khaled ^b,c   Ray, Abhijit ^a,b   Ghandehari, Hamidreza ^a,b  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

bioavailability; drug delivery; oral translocation; PAMAM dendrimers; polymer therapeutics

Indexed keywords

DENDRIMER; POLYAMIDOAMINE;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TRACT; HEART; IN VIVO STUDY; INTESTINE FLUID; KIDNEY; LIVER; LUNG; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPLEEN; ZETA POTENTIAL;

EID: 84874608915     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300436c     Document Type: Article

References (55)

1. Duncan, R. Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 2006, 6 (9) 688-701
2. Harris, J. M.; Chess, R. B. Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discovery 2003, 2 (3) 214-221
3. Pasut, G.; Guiotto, A.; Veronese, F. Protein, peptide and non-peptide drug PEGylation for therapeutic application Expert Opin. Ther. Pat. 2004, 14 (6) 859-894
4. Pachence, J. M.; Belinka, B.; Paul Simon, P. Novel methods for site-directed drug delivery Drug Delivery Technol. 2003, 3 (1) 40-45
5. Kopecek, J.; Kopeckova, P.; Minko, T.; Lu, Z. R.; Peterson, C. M. Water soluble polymers in tumor targeted delivery J. Controlled Release 2001, 74 (1-3) 147-58
6. Duncan, R. The dawning era of polymer therapeutics Nat. Rev. Drug Discovery 2003, 2 (5) 347-60
7. Jani, P.; Halbert, G. W.; Langridge, J.; Florence, A. T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 1990, 42 (12) 821-6
8. Fasano, A. Novel approaches for oral delivery of macromolecules J. Pharm. Sci. 1998, 87 (11) 1351-6
9. Cai, Z.; Wang, Y.; Zhu, L. J.; Liu, Z. Q. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs Curr. Drug Metab. 2010, 11 (2) 197-207
10. Ranaldi, G.; Marigliano, I.; Vespignani, I.; Perozzi, G.; Sambuy, Y. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1) J. Nutr. Biochem. 2002, 13 (3) 157-167
11. Yeh, T. H.; Hsu, L. W.; Tseng, M. T.; Lee, P. L.; Sonjae, K.; Ho, Y. C.; Sung, H. W. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening Biomaterials 2011, 32 (26) 6164-73
12. Sadeghi, A. M.; Dorkoosh, F. A.; Avadi, M. R.; Weinhold, M.; Bayat, A.; Delie, F.; Gurny, R.; Larijani, B.; Rafiee-Tehrani, M.; Junginger, H. E. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells Eur. J. Pharm. Biopharm. 2008, 70 (1) 270-8
13. Hossain, Z.; Hirata, T. Molecular mechanism of intestinal permeability: interaction at tight junctions Mol. Biosyst. 2008, 4 (12) 1181-5
14. Madsen, F.; Peppas, N. A. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition Biomaterials 1999, 20 (18) 1701-8
15. Shakweh, M.; Ponchel, G.; Fattal, E. Particle uptake by Peyer patches: a pathway for drug and vaccine delivery Expert Opin. Drug Delivery 2004, 1 (1) 141-163
16. Des Rieux, A.; Fievez, V.; Garinot, M.; Schneider, Y. J.; Preat, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach J. Controlled Release 2006, 116 (1) 1-27
17. Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. A new class of polymers: starburst-dendritic macromolecules Polym. J. 1985, 17 (1) 117-132
18. Tomalia, D. A.; Reyna, L. A.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochem. Soc. Trans. 2007, 35 (Pt 1) 61-7
19. Menjoge, A. R.; Kannan, R. M.; Tomalia, D. A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications Drug Discovery Today 2010, 15 (5-6) 171-85
20. Svenson, S. Dendrimers as versatile platform in drug delivery applications Eur. J. Pharm. Biopharm. 2009, 71 (3) 445-62
21. Tomalia, D. A.; Dewald, J. R. Dense Star Polymers Having Core, Core Branches, Terminal Groups. U.S. Patent 4,507,466, 1985.
22. Tomalia, D. A. Starburst/Cascade Dendrimers: Fundamental building blocks for a new nanoscopic chemistry set Adv. Mater. 1994, 6 (7-8) 529-539
23. Thiagarajan, G.; Ray, A.; Malugin, A.; Ghandehari, H. PAMAM-camptothecin conjugates inhibit proliferation and induces nuclear fragmentation in colorectal carcinoma cells Pharm. Res. 2010, 27 (11) 2307-16
24. Tomalia, D. A.; Naylor, A. M.; Goddard, W. A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter Angew. Chem., Int. Ed. 1990, 29 (2) 138-175
25. Ward, B. B.; Dunham, T.; Majoros, I. J.; Baker, J. R., Jr. Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma J. Oral Maxillofacial Surg. 2011, 69 (9) 2452-2459
26. Thomas, T. P.; Goonewardena, S. N.; Majoros, I. J.; Kotlyar, A.; Cao, Z.; Leroueil, P. R.; Baker, J. R. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis Arthritis Rheumatism 2011, 63 (9) 2671-2680
27. Malik, N.; Evagorou, E. G.; Duncan, R. Dendrimer-platinate: a novel approach to cancer chemotherapy Anticancer Drugs 1999, 10 (8) 767-76
28. Menjoge, A. R.; Rinderknecht, A. L.; Navath, R. S.; Faridnia, M.; Kim, C. J.; Romero, R.; Miller, R. K.; Kannan, R. M. Transfer of PAMAM dendrimers across human placenta: Prospects of its use as drug carrier during pregnancy J. Controlled Release 2011, 150 (3) 326-338
29. Navath, R. S.; Menjoge, A. R.; Dai, H.; Romero, R.; Kannan, S.; Kannan, R. M. Injectable PAMAM dendrimer,PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation Mol. Pharmaceutics 2011, 8 (4) 1209-1223
30. Inapagolla, R.; Guru, B. R.; Kurtoglu, Y. E.; Gao, X.; Lieh-Lai, M.; Bassett, D. J. P.; Kannan, R. M. In vivo efficacy of dendrimer, methylprednisolone conjugate formulation for the treatment of lung inflammation Int. J. Pharm. 2010, 399 (1-2) 140-147
31. Wiwattanapatapee, R.; Carreno-Gomez, B.; Malik, N.; Duncan, R. Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharm. Res. 2000, 17 (8) 991-8
32. El-Sayed, M.; Ginski, M.; Rhodes, C.; Ghandehari, H. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers J. Controlled Release 2002, 81 (3) 355-65
33. El-Sayed, M.; Rhodes, C. A.; Ginski, M.; Ghandehari, H. Transport mechanism(s) of poly(amidoamine) dendrimers across Caco-2 cell monolayers Int. J. Pharm. 2003, 265 (1-2) 151-7
34. Kitchens, K. M.; Kolhatkar, R. B.; Swaan, P. W.; Eddington, N. D.; Ghandehari, H. Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling Pharm. Res. 2006, 23 (12) 2818-26
35. Goldberg, D. S.; Vijayalakshmi, N.; Swaan, P. W.; Ghandehari, H. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity J. Controlled Release 2011, 150 (3) 318-25
36. Jevprasesphant, R.; Penny, J.; Attwood, D.; McKeown, N. B.; D'Emanuele, A. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity Pharm. Res. 2003, 20 (10) 1543-1550
37. Najlah, M.; Freeman, S.; Attwood, D.; D'Emanuele, A. In vitro evaluation of dendrimer prodrugs for oral drug delivery Int. J. Pharm. 2007, 336 (1) 183-90
38. Goldberg, D. S.; Ghandehari, H.; Swaan, P. W. Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia Pharm. Res. 2010, 27 (8) 1547-57
39. Sadekar, S.; Ghandehari, H. Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery Adv. Drug Delivery Rev. 2012, 64 (6) 571-88
40. Greish, K.; Thiagarajan, G.; Herd, H.; Price, P.; Bauer, H.; Hubbard, D.; Burckle, A.; Sadekar, S.; Yu, T.; Anwar, A.; Ray, A.; Ghandehari, H. Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles Nanotoxicology 2011, 6 (7) 718-728
41. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; Paulus, W.; Duncan, R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo J. Controlled Release 2000, 65 (1-2) 133-48
42. U.S. Pharmacopeia. http://www.usp.org/ (accessed Oct 18, 2011).
43. Shakweh, M.; Besnard, M.; Nicolas, V.; Fattal, E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice Eur. J. Pharm. Biopharm. 2005, 61 (1-2) 1-13
44. Kim, S. K. Small intestine transit time in the normal small bowel study Am. J. Roentgenol. Radium Ther. Nucl. Med. 1968, 104 (3) 522-4
45. Schwarz, R.; Kaspar, A.; Seelig, J.; Künnecke, B. Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance Magn. Reson. Med. 2002, 48 (2) 255-261
46. Qiu, Y.; Chen, Y.; Zhang, G. G. Z.; Liu, L.; Porter, W., Eds. Design, Development, and Scale-up of Formulation and Process. In Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice; Elsevier: Maryland Heights, MO, 2008.
47. Bowman, K.; Leong, K. W. Chitosan nanoparticles for oral drug and gene delivery Int. J. Nanomed. 2006, 1 (2) 117-28
48. Elsayed, A.; Al-Remawi, M.; Qinna, N.; Farouk, A.; Al-Sou'od, K.; Badwan, A. Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin AAPS PharmSciTech 2011, 1-7
49. Saovapakhiran, A.; D'Emanuele, A.; Attwood, D.; Penny, J. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization Bioconjugate Chem. 2009, 20 (4) 693-701
50. Ferraris, R. P.; Villenas, S. A.; Diamond, J. Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine Am. J. Physiol. 1992, 262 (6 Pt 1) G1047-59
51. Adibi, S. A.; Kim, S. K. Peptide Absorption and Hydrolysis. In Physiology of Gastrointestinal Tract; Johnson, L. R. Raven Press: New York, 1981; pp 1073-1095.
52. Wolinsky, J. B.; Grinstaff, M. W. Therapeutic and diagnostic applications of dendrimers for cancer treatment Adv. Drug Delivery Rev. 2008, 60 (9) 1037-55
53. Kojima, C.; Regino, C.; Umeda, Y.; Kobayashi, H.; Kono, K. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers Int. J. Pharm. 2010, 383 (1-2) 293-296
54. Boyd, B. J.; Kaminskas, L. M.; Karellas, P.; Krippner, G.; Lessene, R.; Porter, C. J. H. Cationic poly- l -lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats Mol. Pharmaceutics 2006, 3 (5) 614-627
55. Kenny, A. J.; Maroux, S. Topology of microvillar membrance hydrolases of kidney and intestine Physiol. Rev. 1982, 62 (1) 91-128